Capital Fund Management (CFM)
MEDP icon

Capital Fund Management (CFM)’s Medpace MEDP Stock Holding History

Capital Fund Management (CFM)’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.89M Sell
13,003
-21,415
-62% -$9.88M 0.03% 762
2026
Q1 		$16.5M Sell
34,418
-1,840
-5% -$942K 0.07% 369
2025
Q4 		$20.4M Buy
36,258
+3,846
+12% +$2.18M 0.06% 490
2025
Q3 		$16.7M Buy
32,412
+18,287
+129% +$7.98M 0.04% 594
2025
Q2 		$4.43M Buy
+14,125
New +$4.24M 0.01% 1218
2025
Q1 		– Sell
-24,758
Closed -$8.23M – 2206
2024
Q4 		$8.23M Buy
24,758
+10,520
+74% +$3.57M 0.02% 842
2024
Q3 		$4.75M Buy
14,238
+2,785
+24% +$1.06M 0.01% 1043
2024
Q2 		$4.72M Sell
11,453
-2,667
-19% -$1.06M 0.01% 970
2024
Q1 		$5.71M Sell
14,120
-10,907
-44% -$3.83M 0.02% 988
2023
Q4 		$7.67M Sell
25,027
-14,823
-37% -$4M 0.02% 912
2023
Q3 		$9.65M Buy
39,850
+1,409
+4% +$360K 0.03% 634
2023
Q2 		$9.23M Buy
38,441
+5,764
+18% +$1.2M 0.04% 591
2023
Q1 		$6.14M Sell
32,677
-9,493
-23% -$1.96M 0.03% 665
2022
Q4 		$8.96M Buy
42,170
+3,329
+9% +$665K 0.06% 447
2022
Q3 		$6.1M Sell
38,841
-8,750
-18% -$1.4M 0.05% 481
2022
Q2 		$7.12M Buy
47,591
+12,042
+34% +$1.74M 0.06% 418
2022
Q1 		$5.82M Buy
35,549
+21,064
+145% +$3.47M 0.05% 516
2021
Q4 		$3.15M Buy
+14,485
New +$3.03M 0.02% 827
2020
Q4 		– Sell
-65,827
Closed -$7.36M – 1452
2020
Q3 		$7.36M Sell
65,827
-3,077
-4% -$356K 0.09% 254
2020
Q2 		$6.41M Sell
68,904
-125,223
-65% -$10.7M 0.1% 259
2020
Q1 		$14.2M Sell
194,127
-33,077
-15% -$2.87M 0.22% 132
2019
Q4 		$19.1M Sell
227,204
-29,691
-12% -$2.3M 0.15% 172
2019
Q3 		$21.6M Sell
256,895
-36,452
-12% -$2.75M 0.19% 133
2019
Q2 		$19.2M Buy
293,347
+92,504
+46% +$5.33M 0.17% 164
2019
Q1 		$11.8M Buy
+200,843
New +$12M 0.11% 256
2018
Q4 		– Sell
-22,300
Closed -$1.34M – 2080
2018
Q3 		$1.34M Buy
22,300
+15,200
+214% +$831K 0.01% 1271
2018
Q2 		$305K Buy
+7,100
New +$287K ﹤0.01% 1782

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital Fund Management (CFM)'s MEDP Position: Q2 2026 in Review

Capital Fund Management (CFM) reduced its Medpace (MEDP) stake by 62% in Q2 2026, selling an estimated $9.88M and leaving 13,003 shares worth $6.89M. The position accounts for 0.03% of the portfolio, ranked #762.

Capital Fund Management (CFM) first reported a position in MEDP in Q2 2018 and has held it in 27 quarters since. The position peaked at $21.6M in Q3 2019. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Capital Fund Management (CFM) held 13,003 shares of Medpace worth $6.89M as of Q2 2026.
  • Capital Fund Management (CFM) sold 21,415 Medpace shares in Q2 2026, an estimated $9.88M.
  • Medpace made up 0.03% of Capital Fund Management (CFM)'s portfolio in Q2 2026, its #762 holding.
  • Capital Fund Management (CFM) first reported a position in Medpace in Q2 2018 and has held it in 27 quarters since.
  • Capital Fund Management (CFM)'s Medpace position peaked at $21.6M in Q3 2019.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q2 2026, filed 13 Aug 2026.